• If you are wondering whether Veeva Systems at around US$161 a share is starting to look attractively priced, you are not alone in asking that question right now.
• The stock has risen 4.2% over the past week and 0.7% over the past month, yet it is still down 26.5% year to date and 42.3% over the past year, which can signal shifting views on its potential and risk.
• Recent coverage around Veeva Systems has focused on its role as a cloud software provider to life sciences companies and how its position in that niche continues to shape investor expectations. This context helps frame why some shareholders are reassessing whether the recent share price levels align with what the underlying business might be worth.
• On Simply Wall St's framework, Veeva Systems currently holds a valuation score of 3 out of 6. This suggests that a closer look at different valuation approaches is warranted and that there may be an even more useful lens on valuation to come by the end of this article.

Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what Veeva Systems might be worth by projecting its future cash flows and discounting those amounts back to today using a required rate of return. It is essentially asking what those future dollars are worth in present terms.

For Veeva Systems, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $1.64b. Analyst estimates and Simply Wall St extrapolations suggest projected free cash flow of $2.34b in the 2031 financial year, with intervening years stepping up from around $1.33b in 2026. All figures are in $ and are treated in billions where appropriate.

Aggregating and discounting these projected cash flows results in an estimated intrinsic value of $282.22 per share for Veeva Systems. Compared with a recent share price of about $161, this DCF view indicates the stock is 42.8% undervalued based on the inputs and assumptions used in the model.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 42.8%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

Approach 2: Veeva Systems Price vs Earnings

The P/E ratio is often a useful way to look at a profitable company like Veeva Systems because it relates what you pay for each share to the earnings that the business is currently generating. In general, higher growth expectations and lower perceived risk can justify a higher P/E multiple, while slower growth or higher risk can mean a lower “normal” or “fair” P/E level.

Veeva Systems currently trades on a P/E of about 27.8x. This sits above the Healthcare Services industry average of roughly 26.5x and below the peer group average of about 33.0x. This places the stock somewhere between the broader sector and more highly rated peers.

Simply Wall St’s Fair Ratio for Veeva Systems is 27.5x. This is a proprietary estimate of what the P/E might be given factors such as earnings growth characteristics, profit margins, size, industry and specific risks. Because it adjusts for these company level traits, the Fair Ratio can be more tailored than a simple peer or industry comparison. With the current P/E of 27.8x sitting very close to the Fair Ratio of 27.5x, this approach suggests the stock is priced around its estimated fair level.

Result: ABOUT RIGHT

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Veeva Systems Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach your own story about Veeva Systems to the numbers by linking a clear view of the business, a financial forecast and then a Fair Value that you can compare to the current share price. Each Narrative lives on the Community page, updates automatically when fresh news or earnings arrive, and reflects different perspectives. For example, one investor may align with a higher Fair Value around US$380.00 based on more optimistic revenue and margin assumptions, while another may anchor closer to the lower Fair Value around US$232.80 based on more cautious expectations.

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.